Need help finding what you are looking for?
Contact Us
PUBLISHER: Grand View Research | PRODUCT CODE: 1571462
PUBLISHER: Grand View Research | PRODUCT CODE: 1571462
Contraceptive Drugs And Devices Market Size, Share & Trends Analysis Report By Product (Contraceptive Drugs (Contraceptive Pills, Patch, Injectable), Contraceptive Devices), By Region, And Segment Forecasts, 2024 - 2030
PUBLISHED:
PAGES: 100 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Contraceptive Drugs And Devices Market Size & Trends:
The global contraceptive drugs and devices market size was valued at USD 29.6 billion in 2023 and is projected to grow at a CAGR of 5.9% from 2024 to 2030. The market growth can be attributed to an increase in the number of sexually transmitted diseases (STDs) and unintended pregnancies. A growing number of initiatives taken by the governments to spread awareness about contraception have resulted in market growth. Furthermore, government policies on controlling the population are expected to contribute to market growth.
The government is investing heavily in spreading awareness of STDs and abortion and how they are avoided with the help of contraceptive drugs or devices. The government is also spreading awareness about family planning, which will ultimately help the government in population management. Furthermore, key pharmaceutical companies are investing heavily in research and development to upgrade contraceptive drugs and devices as there is an increased demand for safe and effective contraceptive measures. Therefore, these factors have contributed to the growth of this market.
The increase in the population, especially in the middle and low-income regions, has resulted in market growth, as there is a rise in the popularity of contraceptive measures. With the rise in awareness regarding sexual health and family planning, there is an increased demand for effective contraceptive measures that can help in dealing with unwanted pregnancies. Furthermore, urbanization and changes in lifestyle, such as delaying pregnancy due to professional goals, are adding to the growth of the market.
Global Contraceptive Drugs And Devices Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global contraceptive drugs and devices market report based on product and region.
- Product Outlook (Revenue, USD Million, 2018 - 2030)
- Contraceptive Drugs
- Contraceptive Pills
- Patch
- Injectable
- Contraceptive Devices
- Condoms
- Male Condoms
- Female Condoms
- Subdermal Implants
- Intrauterine Devices (IUDs)
- Copper IUDs
- Hormonal IUDs
- Vaginal Ring
- Diaphragm
- Regional Outlook (Revenue, USD Billion, 2018 - 2030)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Product Code: 978-1-68038-032-3
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Market Definitions
- 1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. Contraceptive Drugs and Devices Market Variables, Trends, & Scope
- 3.1. Market Introduction/Lineage Outlook
- 3.2. Market Size and Growth Prospects (USD Million)
- 3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraints Analysis
- 3.4. Contraceptive Drugs and Devices Market Analysis Tools
- 3.4.1. Porter's Analysis
- 3.4.1.1. Bargaining power of the suppliers
- 3.4.1.2. Bargaining power of the buyers
- 3.4.1.3. Threats of substitution
- 3.4.1.4. Threats from new entrants
- 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
- 3.4.2.1. Political landscape
- 3.4.2.2. Economic and Social landscape
- 3.4.2.3. Technological landscape
- 3.4.2.4. Environmental landscape
- 3.4.2.5. Legal landscape
- 3.4.1. Porter's Analysis
Chapter 4. Contraceptive Drugs and Devices Market: Product Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Contraceptive Drugs and Devices Market: Product Movement Analysis, 2023 & 2030 (USD Million)
- 4.3. Contraceptive Drugs
- 4.3.1. Contraceptive Drugs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.3.2. Contraceptive Pills
- 4.3.2.1. Contraceptive Pills Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.3.3. Patch
- 4.3.3.1. Patch Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.3.4. Injectable
- 4.3.4.1. Injectable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4. Contraceptive Devices
- 4.4.1. Contraceptive Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.2. Condom
- 4.4.2.1. Condom Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.2.2. Male Condom
- 4.4.2.2.1. Male Condom Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.2.3. Female Condom
- 4.4.2.3.1. Female Condom Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.3. Subdermal Implants
- 4.4.3.1. Subdermal Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.4. Intrauterine Devices (IUDs)
- 4.4.4.1. Intrauterine Devices (IUDs) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.4.2. Copper IUDs
- 4.4.4.2.1. Copper IUDs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.4.3. Hormonal IUDs
- 4.4.4.3.1. Hormonal IUDs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.5. Vaginal Ring
- 4.4.5.1. Vaginal Ring Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.6. Diaphragm
- 4.4.6.1. Diaphragm Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Contraceptive Drugs and Devices Market: Regional Estimates & Trend Analysis
- 5.1. Contraceptive Drugs and Devices Market Share, By Region, 2023 & 2030 (USD Billion)
- 5.2. North America
- 5.2.1. North America Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.2.2. U.S.
- 5.2.2.1. U.S. Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.2.3. Canada
- 5.2.3.1. Canada Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.2.4. Mexico
- 5.2.4.1. Mexico Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.3. Europe
- 5.3.1. Europe Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.3.2. UK
- 5.3.2.1. UK Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.3.3. Germany
- 5.3.3.1. Germany Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.3.4. France
- 5.3.4.1. France Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.3.5. Italy
- 5.3.5.1. Italy Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.3.6. Spain
- 5.3.6.1. Spain Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.3.7. Denmark
- 5.3.7.1. Denmark Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.3.8. Sweden
- 5.3.8.1. Sweden Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.3.9. Norway
- 5.3.9.1. Norway Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.4. Asia Pacific
- 5.4.1. Asia Pacific Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.4.2. Japan
- 5.4.2.1. Japan Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.4.3. China
- 5.4.3.1. China Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.4.4. India
- 5.4.4.1. India Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.4.5. Australia
- 5.4.5.1. Australia Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.4.6. South Korea
- 5.4.6.1. South Korea Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.4.7. Thailand
- 5.4.7.1. Thailand Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.5. Latin America
- 5.5.1. Latin America Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.5.2. Brazil
- 5.5.2.1. Brazil Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.5.3. Argentina
- 5.5.3.1. Argentina Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6. Middle East and Africa
- 5.6.1. Middle East and Africa Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6.2. South Africa
- 5.6.2.1. South Africa Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6.3. Saudi Arabia
- 5.6.3.1. Saudi Arabia Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6.4. UAE
- 5.6.4.1. UAE Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6.5. Kuwait
- 5.6.5.1. Kuwait Contraceptive Drugs and Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Competitive Landscape
- 6.1. Recent Developments & Impact Analysis by Key Market Participants
- 6.2. Company Categorization
- 6.3. Company Heat Map Analysis
- 6.4. Company Profiles
- 6.4.1. Abbvie, Inc.
- 6.4.1.1. Participant's Overview
- 6.4.1.2. Financial Performance
- 6.4.1.3. Product Benchmarking
- 6.4.1.4. Recent Developments/ Strategic Initiatives
- 6.4.2. Afaxys, Inc.
- 6.4.2.1. Participant's Overview
- 6.4.2.2. Financial Performance
- 6.4.2.3. Product Benchmarking
- 6.4.2.4. Recent Developments/ Strategic Initiatives
- 6.4.3. Agile Therapeutics
- 6.4.3.1. Participant's Overview
- 6.4.3.2. Financial Performance
- 6.4.3.3. Product Benchmarking
- 6.4.3.4. Recent Developments/ Strategic Initiatives
- 6.4.4. Bayer AG
- 6.4.4.1. Participant's Overview
- 6.4.4.2. Financial Performance
- 6.4.4.3. Product Benchmarking
- 6.4.4.4. Recent Developments/ Strategic Initiatives
- 6.4.5. China Resources (Holdings) Co., Ltd.
- 6.4.5.1. Participant's Overview
- 6.4.5.2. Financial Performance
- 6.4.5.3. Product Benchmarking
- 6.4.5.4. Recent Developments/ Strategic Initiatives
- 6.4.6. Church & Dwight Co., Inc.
- 6.4.6.1. Participant's Overview
- 6.4.6.2. Financial Performance
- 6.4.6.3. Product Benchmarking
- 6.4.6.4. Recent Developments/ Strategic Initiatives
- 6.4.7. Cupid Limited
- 6.4.7.1. Participant's Overview
- 6.4.7.2. Financial Performance
- 6.4.7.3. Product Benchmarking
- 6.4.7.4. Recent Developments/ Strategic Initiatives
- 6.4.8. Helm AG
- 6.4.8.1. Participant's Overview
- 6.4.8.2. Financial Performance
- 6.4.8.3. Product Benchmarking
- 6.4.8.4. Recent Developments/ Strategic Initiatives
- 6.4.9. Johnson & Johnson Services, Inc.
- 6.4.9.1. Participant's Overview
- 6.4.9.2. Financial Performance
- 6.4.9.3. Product Benchmarking
- 6.4.9.4. Recent Developments/ Strategic Initiatives
- 6.4.10. Organon Group of Companies
- 6.4.10.1. Participant's Overview
- 6.4.10.2. Financial Performance
- 6.4.10.3. Product Benchmarking
- 6.4.10.4. Recent Developments/ Strategic Initiatives
- 6.4.11. Pfizer Inc.
- 6.4.11.1. Participant's Overview
- 6.4.11.2. Financial Performance
- 6.4.11.3. Product Benchmarking
- 6.4.11.4. Recent Developments/ Strategic Initiatives
- 6.4.12. Veru, Inc.
- 6.4.12.1. Participant's Overview
- 6.4.12.2. Financial Performance
- 6.4.12.3. Product Benchmarking
- 6.4.12.4. Recent Developments/ Strategic Initiatives
- 6.4.13. Viatris Inc.
- 6.4.13.1. Participant's Overview
- 6.4.13.2. Financial Performance
- 6.4.13.3. Product Benchmarking
- 6.4.13.4. Recent Developments/ Strategic Initiatives
- 6.4.1. Abbvie, Inc.
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.